DSG1 and pemphigus: Nevertheless, since topical application of Dsg-crosslinking peptides or drugs to increase cAMP were effective in pemphigus mouse models in vivo (216, 334) it may also be possible to reduce side-effects by site-specific application of modulators of signalling pathways in the future.